Comera Life Sciences Valuation
| CMRADelisted Stock | USD 0.66 0.01 1.54% |
Comera Life is overvalued. Comera Life Sciences shows a prevailing Real Value of $0.54 per share. The current price of the firm is $0.66. Our model approximates the value of Comera Life Sciences from analyzing the firm fundamentals such as Operating Margin of (15.82) %, shares outstanding of 30.74 M, and Return On Equity of -16.29 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Comera Life's price fluctuation is very steady at this time. Calculation of the real value of Comera Life Sciences is based on 3 months time horizon. Increasing Comera Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Comera Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Comera Pink Sheet. However, Comera Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.66 | Real 0.54 | Hype 0.66 | Naive 0.67 |
The real value of Comera Pink Sheet, also known as its intrinsic value, is the underlying worth of Comera Life Sciences Company, which is reflected in its stock price. It is based on Comera Life's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Comera Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Comera Life Sciences helps investors to forecast how Comera pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Comera Life more accurately as focusing exclusively on Comera Life's fundamentals will not take into account other important factors: Comera Life Total Value Analysis
Comera Life Sciences is currently projected to have valuation of 9.96 M with market capitalization of 6.85 M, debt of 775.05 K, and cash on hands of 4.94 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Comera Life fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.96 M | 6.85 M | 775.05 K | 4.94 M |
Comera Life Investor Information
About 51.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.22. Comera Life Sciences had not issued any dividends in recent years. The entity had 1:1 split on the 20th of May 2022. Based on the measurements of operating efficiency obtained from Comera Life's historical financial statements, Comera Life Sciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Comera Life Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Comera Life has an asset utilization ratio of 16.99 percent. This suggests that the Company is making $0.17 for each dollar of assets. An increasing asset utilization means that Comera Life Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Comera Life Ownership Allocation
Comera Life holds a total of 30.74 Million outstanding shares. Comera Life Sciences retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Comera Life Profitability Analysis
The company reported the previous year's revenue of 633.1 K. Net Loss for the year was (18 M) with profit before overhead, payroll, taxes, and interest of 422.71 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Comera Life's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Comera Life and how it compares across the competition.
About Comera Life Valuation
The pink sheet valuation mechanism determines Comera Life's current worth on a weekly basis. Our valuation model uses a comparative analysis of Comera Life. We calculate exposure to Comera Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Comera Life's related companies.Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts. Comera Life operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 9 people.
8 Steps to conduct Comera Life's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Comera Life's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Comera Life's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Comera Life's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Comera Life's revenue streams: Identify Comera Life's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Comera Life's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Comera Life's growth potential: Evaluate Comera Life's management, business model, and growth potential.
- Determine Comera Life's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Comera Life's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Comera Life Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 10.5 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in Comera Pink Sheet
If you are still planning to invest in Comera Life Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Comera Life's history and understand the potential risks before investing.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |